Sv Health Investors 13F annual report
Sv Health Investors is an investment fund managing more than $32.3 million ran by Brent Faduski. There are currently 4 companies in Mr. Faduski’s portfolio. The largest investments include Bicycle Therapeutics plc and Bioventus, Inc, together worth $31.5 million.
$32.3 million Assets Under Management (AUM)
As of 31st October 2022, Sv Health Investors’s top holding is 907,032 shares of Bicycle Therapeutics plc currently worth over $21.1 million and making up 65.4% of the portfolio value.
Relative to the number of outstanding shares of Bicycle Therapeutics plc, Sv Health Investors owns more than approximately 0.1% of the company.
In addition, the fund holds 1,488,596 shares of Bioventus, Inc worth $10.4 million.
The third-largest holding is X4 Pharmaceuticals worth $532 thousand and the next is Asensus Surgical Inc worth $229 thousand, with 510,142 shares owned.
Currently, Sv Health Investors's portfolio is worth at least $32.3 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Sv Health Investors
The Sv Health Investors office and employees reside in Boston, Massachusetts. According to the last 13-F report filed with the SEC, Brent Faduski serves as the Officer at Sv Health Investors.
Recent trades
There are companies that Sv Health Investors is getting rid of from its portfolio.
Sv Health Investors closed its position in AdaptHealth on 7th November 2022.
It sold the previously owned 1,290,978 shares for $20.7 million.
Brent Faduski also disclosed a decreased stake in Bicycle Therapeutics plc by approximately 0.1%.
This leaves the value of the investment at $21.1 million and 907,032 shares.
One of the smallest hedge funds
The two most similar investment funds to Sv Health Investors are Cross Creek Advisors and Strategic Vision Investment Ltd. They manage $32.2 million and $32.4 million respectively.
Brent Faduski investment strategy
Sv Health Investors’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 67.7% of
the total portfolio value.
The fund focuses on investments in the United Kingdom as
25.0% of the portfolio companies
are based in the United Kingdom.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $311 million.
The complete list of Sv Health Investors trades based on 13F SEC filings
These positions were updated on November 7th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Bicycle Therapeutics plc |
1.11%
907,032
|
$21,098,000 | 65.36% |
| AdaptHealth Corp. |
Closed
1,290,978
|
$20,694,000 | |
| Bioventus, Inc |
No change
1,488,596
|
$10,420,000 | 32.28% |
| X4 Pharmaceuticals, Inc. |
No change
311,490
|
$532,000 | 1.65% |
| Asensus Surgical Inc |
No change
510,142
|
$229,000 | 0.71% |
| No transactions found | |||
| Showing first 500 out of 5 holdings | |||
Hedge funds similar to Sv Health Investors
- Gryphon International Investment Corp
- H2o Am LL.P.
- Emergence Gp Partners
- Hudson Structured Capital Management
- Interwest Venture Management Co
- Kids Capital Management, L.P.
- Strategic Vision Investment Ltd
- Cross Creek Advisors
- Norwest Venture Partners Xi, L.P.
- Ciovacco Capital Management
- Scff Management
- Caz Investments L.P.
- Virginia National Bank
- Mcclarren Advisors